Copy
EuropaBio's Weekly Newsletter

Time for the European Commission to act

When adopting Implementing Regulation No 503/2013, the European Commission included a mandatory 90-day feeding trial for GM food and feed risk assessment. During their final conference, GRACE, a European Commission project initiated in 2012, determined that there is no scientific justification for a mandatory 90-day feeding study, but instead it should be hypothesis-driven and case-by-case. EuropaBio firmly believes that the EU risk assessment should respect the case-by-case approach and only request studies with scientific added value depending on the properties of each individual GMO.

Towards a low-carbon, secure and competitive economy

The first State of the Energy Union Report looks at progress made over the last nine months, identifies key action areas for 2016 and provides policy conclusions at Member State, regional and European level. Maroš Šefčovič, Vice-President of the European Commission, said: "My messages for 2016 are clear. First, the EU should continue to lead in the transition to a low-carbon economy. Second, that transition should be socially fair and consumer-centred. And third, the geopolitical challenges that we faced this year will not go away." Do you know that the bioeconomy helps reduce greenhouse gas emissions? How do we make it a reality?

Flashback in pictures to EFIB 2015
 

Healthcare biotech

The European Commission is proposing to review the 2003 Communication on orphan medicinal products to streamline the regulatory framework and to adapt the Communication to technical progress. The 2003 Communication will be replaced by a notice and public consultations will be open until 15 February 2016.
 

Agricultural biotech

The Swedish Board of Agriculture confirmed the interpretation that some plants in which the genome has been edited using the CRISPR-Cas9 technology do not fall under the European GMO definition. This is important for the wide use of such plants to contribute to solving some of the escalating challenges of mankind.

Industrial biotech

IKEA committed to only use plastics made from renewable or recycled sources by the year 2020. Per Stoltz, sustainability developer at IKEA, announced the company would favour plastics made from second-generation cellulosic sugars. Even though IKEA may pay a  price premium for bioplastics, it will not pass that on to customers.

Key dates to keep in mind
https://www.facebook.com/pages/EuropaBio/74765722914
https://www.linkedin.com/company/europabio
http://www.europabio.org/
Copyright © *2015* *EuropaBio*, All rights reserved.

Our mailing address is:
Avenue de l'Armée 6
B-1040 Brussels

unsubscribe from this list